Drug: Bevacizumab Injury: Ascites Quarter: 2016Q3
Total Records: 20 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 81331126 | Bevacizumab | Ascites | ROCHE | 0.00 | F | 0 | 20160912 | US |
| 105726027 | Bevacizumab | Ascites | ROCHE | 62.60 YR | F | 71 KG | 20160830 | DE |
| 120387423 | Bevacizumab | Ascites | ROCHE | 56.00 YR | F | 0 | 20160726 | NL |
| 122249966 | Bevacizumab | Ascites | ROCHE | 74.00 YR | M | 0 | 20160915 | DE |
| 123686475 | BEVACIZUMAB | Ascites | MERCK | 8.00 YR | F | 0 | 20160712 | US |
| 126065282 | BEVACIZUMAB | Ascites | BRISTOL MYERS SQUIBB | 64.00 YR | M | 0 | 20160819 | US |
| 126101391 | Bevacizumab | Ascites | ROCHE | 0.00 | 0 | 20160801 | IT | |
| 126287821 | BEVACIZUMAB | Ascites | ACCORD | 52.00 YR | F | 0 | 20160808 | JP |
| 126288391 | BEVACIZUMAB | Ascites | ACCORD | 0.00 | 0 | 20160808 | JP | |
| 126288651 | BEVACIZUMAB | Ascites | ACCORD | 0.00 | 0 | 20160808 | JP | |
| 126288671 | BEVACIZUMAB | Ascites | ACCORD | 0.00 | 0 | 20160808 | JP | |
| 126292041 | BEVACIZUMAB | Ascites | ACCORD | 0.00 | 0 | 20160808 | JP | |
| 126433161 | Bevacizumab | Ascites | ROCHE | 73.00 YR | M | 0 | 20160811 | JP |
| 127448901 | Bevacizumab | Ascites | ROCHE | 76.00 YR | F | 73 KG | 20160915 | US |
| 127450621 | Bevacizumab | Ascites | ROCHE | 62.41 YR | M | 75 KG | 20160915 | US |
| 127451461 | Bevacizumab | Ascites | ROCHE | 76.00 YR | F | 61 KG | 20160915 | US |
| 127882491 | Bevacizumab | Ascites | ROCHE | 60.00 YR | F | 54 KG | 20160928 | US |
| 127908091 | Bevacizumab | Ascites | ROCHE | 73.00 YR | F | 84 KG | 20160929 | US |
| 127980861 | Bevacizumab | Ascites | ROCHE | 61.00 YR | F | 57 KG | 20160930 | US |
| 127984111 | Bevacizumab | Ascites | ROCHE | 82.00 YR | F | 50 KG | 20160930 | US |
Total Records: 20 Number of Pages: 1